Advertisement

Topics

Public offering nets $93mm for Catalyst Biosciences

14:40 EST 14 Feb 2018 | Elsevier Business Intelligence

Catalyst Biosciences Inc. netted $93mm through the public sale of 2.94mm common shares at $34. Some of the proceeds will supp...

Original Article: Public offering nets $93mm for Catalyst Biosciences

NEXT ARTICLE

More From BioPortfolio on "Public offering nets $93mm for Catalyst Biosciences"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...